Long-term Treatment of Severe Recalcitrant Atopic Dermatitis with Omalizumab, an Anti-immuno- globulin E

Author: Quist Sven R.   Ambach Andreas   Göppner Daniela   Quist Jennifer   Franke Ingolf   Bonnekoh Bernd   Gollnick Harald P.M.  

Publisher: Medical Journals Limited

ISSN: 0001-5555

Source: Acta Dermato-Venereologica, Vol.93, Iss.2, 2013-03, pp. : 206-208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content